Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -107,254 | -135,117 | -279,818 | -303,659 | -167,475 |
| Depreciation Amortization | 3,130 | 16,001 | 4,176 | 6,364 | 4,628 |
| Income taxes - deferred | N/A | -32 | N/A | N/A | N/A |
| Accounts receivable | 1,206 | 9,333 | -3,706 | 11,032 | -17,016 |
| Other Working Capital | -2,665 | -10,260 | 19,834 | 50,352 | -71,072 |
| Other Operating Activity | 1,506 | -4,291 | 43,299 | 20,203 | 72,955 |
| Operating Cash Flow | $-104,077 | $-124,366 | $-216,215 | $-215,709 | $-177,979 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 104,500 | 81,458 | -248,529 | -348,953 | -156,217 |
| PPE Investments | -429 | 5,898 | -969 | -1,231 | -1,521 |
| Purchase Of Investment | N/A | N/A | -2,000 | N/A | -1,400 |
| Sale Of Investment | N/A | N/A | 361,084 | 174,840 | 103,116 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -2,775 |
| Investing Cash Flow | $104,071 | $87,356 | $109,586 | $-175,345 | $-58,796 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 172 |
| Debt Repayment | -16,415 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 68,311 | 5,462 | 83,238 | 216,110 | 466,756 |
| Other Financing Activity | -421 | -467 | -1,398 | -4,611 | -1,648 |
| Financing Cash Flow | $51,476 | $4,995 | $81,841 | $211,499 | $465,280 |
| Exchange Rate Effect | 32 | -4 | -26 | -30 | 27 |
| Beginning Cash Position | 14,311 | 46,329 | 71,144 | 250,728 | 22,196 |
| End Cash Position | 65,813 | 14,311 | 46,329 | 71,144 | 250,728 |
| Net Cash Flow | $51,502 | $-32,019 | $-24,814 | $-179,584 | $228,532 |
| Free Cash Flow | |||||
| Operating Cash Flow | -104,077 | -124,366 | -216,215 | -215,709 | -177,979 |
| Capital Expenditure | -488 | -321 | -969 | -1,231 | -1,521 |
| Free Cash Flow | -104,564 | -124,687 | -217,185 | -216,940 | -179,500 |